Galapagos | GLPG - Ebitda

Precio De Mercado
26.48
Cambio Diario
-0.10 -0.38%
Mensual
-6.83%
Anual
11.92%
Q1 Expectativa
25.60




Ebitda Cambio Fecha
argenx SE USD 387.05M 99.02M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Genmab DKK 186M 291M 2025-12
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
GRIFOLS EUR 347.24M 58.35M 2025-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Incyte USD 414.5M 92.42M 2025-12
Merck EUR 1.44B 263M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 4.77B 1.11B 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
UCB EUR 1.6B 570M 2025-12
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09